Medical Xpress

Minimally invasive transperineal laser ablation of the prostate appears effective

Minimally invasive transperineal laser ablation (TPLA) of the prostate appears effective for benign prostatic hyperplasia (BPH), according to a review published online Sept. 21 in Therapeutic Advances ...
Cancer Therapy Advisor

Early Outcomes of Water Vapor Tx Ablation for GG2 Prostate Cancer

Investigators reported initial results from the VAPOR 2 study, which assessed partial gland water vapor ablation in men with grade group 2 prostate cancer.
Morningstar%2c Inc.

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) Prospective Feasibility ...
RAPS

FDA guidance addresses ultrasonic prostate ablation submissions

A new final guidance from the US Food and Drug Administration (FDA) addresses clinical testing and clinical data collection to support marketing authorizations for high intensity ultrasound systems to ...
Nasdaq

Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology ...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
MedPage Today

Overactive Bladder and Dysuria Following Transurethral Interventions for Benign Prostatic Enlargement

—A recent meta-analysis of 35 studies showed that TURP was associated with lower odds of early and persistent LUTS compared with ablation and enucleation. After surgery for benign prostatic ...
Nasdaq

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

Prospective Feasibility Study to Examine IRE as a Tissue-Sparing, Minimally Invasive Option for Men with BPH-Related Lower Urinary Tract Symptoms BPH is among the most prevalent urologic conditions ...